美多芭方案应用于帕金森病的治疗
 |
| 第1页 |
参见附件(1434KB，2页)。
【摘要】 目的 通过对比分析美多芭方案治疗帕金森的临床效果,为临床医师选择最佳治疗药物提供依据。方法 选择2004年10月至2009年9月在我院就诊的患者107例,分为美多芭组(35例),美多芭+吡贝地尔组(36例)及美多芭+安坦组(36例),分析三组方案对帕金森的治疗。结果 美多芭与吡贝地尔联用对帕金森的治疗有效率为88.9%,优于美多芭与安坦联用(83.3%)及美多芭单用(74.3%),且差异有显著性。治疗6个月后,美多芭与吡贝地尔组帕金森病统一评分量表(UPDRS)评分减低明显。结论 美多芭与多巴胺受体激动剂联合应用是目前值得提倡的一种较新的治疗方案,值得临床推广。
【关键词】 帕金森;美多芭;吡贝地尔;安坦;帕金森病统一评分量表
Observation of the curative effects of-adopar for treatment on Parkinson disease
WANG Wen-feng.Department of neurdogy,Chaonan MinSheng Hospital of Shantou,Shantou 515144,China
【Abstract】 Objective To investigate the clinical efficacy of modopar in treatment of parkinson and provide drug information for clinicists.Methods 107 cases with parkinson were selected as treatment groups,35 of them were treated with modopar,36 of them were treated with modopar+piribedil,and the other 36 were treated with modopar+artane.Results Effective percentage was 88.9%in modopar+piribedil group,compared with that 83.3%in modopar+artane group and 74 ......
您现在查看是摘要介绍页，详见PDF附件(1434KB，2页)。